Yinka Ogundimu
About Yinka Ogundimu
Yinka Ogundimu serves as the Senior Director of Clinical Quality Assurance at Mirati Therapeutics, a position he has held since 2021. He has over a decade of experience in clinical quality assurance and compliance, having previously worked at Merck in various roles for ten years.
Work at Mirati Therapeutics
Yinka Ogundimu has been serving as the Senior Director of Clinical Quality Assurance at Mirati Therapeutics since 2021. In this role, he oversees clinical quality processes and ensures compliance with regulatory standards. His responsibilities include managing clinical quality assurance activities and implementing best practices to enhance the quality of clinical trials. His tenure at Mirati Therapeutics has contributed to the company's commitment to advancing innovative therapies.
Previous Experience at Merck
Prior to joining Mirati Therapeutics, Yinka Ogundimu worked at Merck for a decade, holding various positions. He served as a Senior GCP Compliance Specialist from 2010 to 2020, where he focused on Good Clinical Practice compliance. He was promoted to Director in 2020, a role he held for one year before transitioning to Mirati. He also held the position of Associate Director from 2017 to 2020, contributing to clinical quality initiatives.
Educational Background
Yinka Ogundimu holds a Bachelor's degree in Biochemistry from the University of Ibadan, which he completed from 1991 to 1997. He furthered his education by obtaining a Master's degree in Clinical Research Organization and Management from Drexel University, studying from 2007 to 2009. Additionally, he studied at Seneca Polytechnic, enhancing his knowledge and skills in the field.
Experience in Clinical Research and Auditing
Yinka Ogundimu has extensive experience in clinical research and auditing. He worked as an Auditor at Allied Research International from 2002 to 2004 and at ICON Clinical Research for 11 months in 2005. His auditing roles involved assessing compliance with clinical trial protocols and regulatory requirements, which provided him with a solid foundation in clinical quality assurance.